Patents by Inventor Tania Incitti

Tania Incitti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • miR-31 in duchenne muscular dystrophy therapy
    Patent number: 9034838
    Abstract: The invention relates to the therapy of Duchenne Muscular Dystrophy (DMD) by means of modulating the amount of a specific miRNA (miR-31).
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: May 19, 2015
    Assignee: UNIVERSITA DEGLI STUDI DI ROMA “LA SAPIENZA”
    Inventors: Irene Bozzoni, Julie Martone, Davide Cacchiarelli, Tania Incitti
  • miR-31 IN DUCHENNE MUSCULAR DYSTROPHY THERAPY
    Publication number: 20120129920
    Abstract: The invention relates to the therapy of Duchenne Muscular Dystrophy (DMD) by means of modulating the amount of a specific miRNA (miR-31).
    Type: Application
    Filed: May 24, 2010
    Publication date: May 24, 2012
    Applicant: UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA"
    Inventors: Irene Bozzoni, Julie Martone, Davide Cacchiarelli, Tania Incitti
  • MODIFIED snRNAs FOR USE IN THERAPY
    Publication number: 20110301218
    Abstract: The invention relates to a nucleic acid encoding a small nuclear RNA (snRNA), which snRNA is modified so that it contains sequence capable of hybridizing with the 5? and 3? splice site junctions and an exonic splicing enhancer of an exon of a pre-mRNA, so that the exon sequence is skipped during the splicing process that converts the pre-mRNA in the mature mRNA. The nucleic acid, the modified snRNA and vectors incorporating the nucleic acid may be used in the therapy, in particular in the treatment of muscular dystrophies.
    Type: Application
    Filed: February 11, 2011
    Publication date: December 8, 2011
    Inventors: Irene Bozzoni, Femanda De Angelis, Tania Incitti